Pediatric Hypercalciuria Workup

  • Author: Sahar Fathallah-Shaykh, MD; Chief Editor: Craig B Langman, MD   more...
 
Updated: Aug 3, 2011
 

Laboratory Studies

As stated in the previous section, many different processes and disease states can produce overlapping symptoms and similar findings on urinalysis. A directed stepwise approach is important in the evaluation of a child with symptoms or a history compatible with hypercalciuria to avoid unnecessary expense, exposure to radiation, and patient discomfort. The first task is to document hypercalciuria. Looking for commonly associated urinary findings or problems that can produce similar symptoms is also easy and inexpensive. Consequently, the initial approach to any child with urgency, hematuria, or suspected hypercalciuria should include the following:

Urinalysis

A urinary tract infection is suggested by the presence of leukocyte esterase, WBCs, nitrite, or bacteria on microscopic examination findings. A urinalysis also can identify hematuria, a common but insensitive and nonspecific finding in children with hypercalciuria. The urine pH and the presence of crystals also may help identify possible clues or an explanation of the observed symptoms. Uric acid and calcium oxalate crystals are usually seen in acidic urine, whereas calcium phosphate and carbonate crystals are usually seen in alkaline urine. Similarly to hematuria, the presence of crystals or an abnormal pH is neither sensitive nor specific for hypercalciuria.

Urine calcium, creatinine, and uric acid

Not only does this study function as a reasonable screening test to document hypercalciuria, but it also reveals hyperuricosuria. The calcium-to-creatinine and uric acid–to-creatinine ratios should be calculated to determine whether or not abnormalities are present.

The normal calcium-to-creatinine ratio in children is less than 0.2. If the calculated ratio is higher than 0.2, repeat testing is indicated. One approach is to recheck the ratio at monthly intervals for 2 months. If the follow-up ratios are normal, then no additional testing for hypercalciuria is needed. On the other hand, if the ratio remains elevated, a timed 24-hour urine collection should be obtained and the calcium excretion calculated. The 24-hour calcium excretion test is the criterion standard for the diagnosis of hypercalciuria. If the calcium excretion is higher than 4 mg/kg/d, the diagnosis of hypercalciuria is confirmed and further evaluation is warranted.

If hyperuricosuria is detected, the appropriate evaluation for this condition should be initiated.

Follow-up testing

Once hypercalciuria has been diagnosed, several follow-up tests should be considered to search for an underlying etiology. If excess dietary intake or gut absorption of calcium is a concern, a simple way to verify or refute this notion is to temporarily limit dietary calcium intake and retest. The American Academy of Pediatrics (AAP) policy statement recommends that the daily calcium intake equal 800 mg in healthy children aged 4-8 years and 1300 mg in healthy children aged 9-18 years. If hypercalciuria is detected, place the child on a diet consisting of one-half the recommended daily allowance of calcium for 5 days and remeasure the urinary calcium excretion. If the calcium excretion normalizes, allow the child to resume a diet with an appropriate calcium content and reassess. If the urinary calcium excretion is still elevated despite reduced dietary intake, further testing is indicated.

Other laboratory tests

Other tests that are appropriate when trying to establish the cause of the hypercalciuria include serum vitamin D, vitamin A, phosphate, bicarbonate, creatinine, alkaline phosphatase, calcium, magnesium, pH, and parathyroid hormone levels. Freshly voided urine should be measured for bicarbonate and pH. A 24-hour urine collection also should be collected for measurement of calcium, phosphorus, sodium, and magnesium.

Urine calcium-to-osmolality ratio

In children with decreased muscle mass, urine calcium-to-osmolality ratio has been suggested as a more specific and sensitive screening test than calcium-to-creatinine ratio because of decreased urine creatinine excretion in those patients. A urine calcium-to-osmolality ratio (X 10) of less than 0.25 is considered to be suggestive of hypercalciuria.

Next

Imaging Studies

Several imaging studies may be helpful in identifying underlying renal abnormalities or nephrolithiasis.

  • A good place to start is with ultrasonography of the urinary tract. This reveals most major malformations, nephrocalcinosis, and many stones.
  • Renal calyceal microlithiasis represents the presence of hyperechoic spots smaller than 3 mm in diameter in the renal calyces. In one study, renal calyceal microlithiasis was suggested to be present in as many as 85% of children with idiopathic hypercalciuria and did not seem to indicate an increased risk of lithiasis.[5]
  • If urinary tract stones are still a strong consideration despite normal ultrasound findings, a noncontrast helical CT scan is indicated. This has been shown to be a very sensitive and specific modality for identifying renal stones.
  • Large proportions of stones are calcified and may be revealed using plain radiography of the abdomen, but this technique may miss a significant number of stones that are small or uncalcified.
  • Intravenous pyelography (IVP) was widely used in the past to identify renal stones but is not used much in children anymore because of poorer image quality than CT scanning, larger radiation exposure, and potential toxicity of the contrast material. The cost is fairly equivocal.
  • Follow-up imaging may be needed to assess new stone formation, progression, or resolution.
  • Other radiographic studies may be indicated if metabolic bone disease is suspected or if a need to determine bone density exists. Plain radiography of the left hand or knees may be helpful to measure bone age. A dual energy x-ray absorptiometry (DEXA) scan can be used to determine bone density initially or follow bone density in children who require calcium-restricted diets. In children with idiopathic hypercalciuria, bone mineral density (BMD) measurements have consistently disclosed decreased Z-scores at the lumbar spine and, to a lesser extent, at the femoral neck.[6]
Previous
Next

Procedures

  • Unless renal stones form and are not spontaneously passed, procedures are not usually necessary in the evaluation of children with hypercalciuria.
Previous
 
 
Contributor Information and Disclosures
Author

Sahar Fathallah-Shaykh, MD  Assistant Professor in Pediatric Nephrology, University of Alabama at Birmingham School of Medicine; Consulting Staff, Division of Pediatric Nephrology, Medical Director of Pediatric Dialysis Unit, Children's of Alabama

Sahar Fathallah-Shaykh, MD is a member of the following medical societies: American Society of Nephrology and American Society of Pediatric Nephrology

Disclosure: emedecine Honoraria Other

Coauthor(s)

Taylor S Troischt, MD  Clinical Assistant Professor of Pediatrics, West Virginia University Hospitals; Medical Director, Cheat Lake Physicians

Taylor S Troischt, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Pediatrics, and Phi Beta Kappa

Disclosure: Nothing to disclose.

Richard Neiberger, MD, PhD  Director of Pediatric Renal Stone Disease Clinic, Associate Professor, Department of Pediatrics, Division of Nephrology, University of Florida College of Medicine and Shands Hospital

Richard Neiberger, MD, PhD is a member of the following medical societies: American Academy of Pediatrics, American Federation for Medical Research, American Medical Association, American Society of Nephrology, American Society of Pediatric Nephrology, Christian Medical & Dental Society, Florida Medical Association, International Society for Peritoneal Dialysis, International Society of Nephrology, National Kidney Foundation, New York Academy of Sciences, Shock Society, Sigma Xi, Southern Medical Association, Southern Society for Pediatric Research, and Southwest Pediatric Nephrology Study Group

Disclosure: The Osler Institute Honoraria Speaking and teaching

Specialty Editor Board

Deogracias Pena, MD  Medical Director of Dialysis, Department of Pediatrics, Cook Children's Medical Center; Clinical Associate Professor, Texas Tech University School of Medicine

Deogracias Pena, MD is a member of the following medical societies: American Academy of Pediatrics, American Medical Association, and American Society of Pediatric Nephrology

Disclosure: Nothing to disclose.

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Frederick J Kaskel, MD, PhD  Director of the Division and Training Program in Pediatric Nephrology, Vice Chair, Department of Pediatrics, Montefiore Medical Center and Albert Einstein School of Medicine

Frederick J Kaskel, MD, PhD is a member of the following medical societies: American Academy of Pediatrics, American Association for the Advancement of Science, American Pediatric Society, American Physiological Society, American Society of Nephrology, American Society of Pediatric Nephrology, American Society of Transplantation, Eastern Society for Pediatric Research, Federation of American Societies for Experimental Biology, International Society of Nephrology, National Kidney Foundation, New York Academy of Sciences, Renal Physicians Association, Sigma Xi, and Society for Pediatric Research

Disclosure: Nothing to disclose.

Howard Trachtman, MD  Program Director, Pediatrics Research, Schneider Children's Hospital, Department of Pediatrics, Division of Nephrology, Professor, Albert Einstein College of Medicine

Howard Trachtman, MD is a member of the following medical societies: American Society of Hypertension, American Society of Nephrology, American Society of Pediatric Nephrology, and Society for Pediatric Research

Disclosure: Nothing to disclose.

Chief Editor

Craig B Langman, MD  The Isaac A Abt, MD, Professor of Kidney Diseases, Northwestern University, The Feinberg School of Medicine; Division Head of Kidney Diseases, Children's Memorial Hospital

Craig B Langman, MD is a member of the following medical societies: American Academy of Pediatrics, American Society of Nephrology, and International Society of Nephrology

Disclosure: Merck Grant/research funds None; NIH Grant/research funds None; Raptor Pharmaceuticals, Inc Grant/research funds None; Alexion Pharmaceuticals, Inc. Grant/research funds None

References
  1. Srivastava T, Alon US. Pathophysiology of hypercalciuria in children. Pediatr Nephrol. Oct 2007;22(10):1659-73. [Medline].

  2. Worcester EM, Coe FL. New insights into the pathogenesis of idiopathic hypercalciuria. Semin Nephrol. Mar 2008;28(2):120-32. [Medline].

  3. Duffey BG, Pedro RN, Kriedberg C, Weiland D, Melquist J, Ikramuddin S, et al. Lithogenic risk factors in the morbidly obese population. J Urol. Apr 2008;179(4):1401-6. [Medline].

  4. Ayoob R, Wang W, Schwaderer A. Body fat composition and occurrence of kidney stones in hypercalciuric children. Pediatr Nephrol. Jun 10 2011;[Medline].

  5. Escribano J, Balaguer A, Martin R. Childhood idiopathic hypercalciuria--clinical significance of renal calyceal microlithiasis and risk of calcium nephrolithiasis. Scand J Urol Nephrol. 2004;38(5):422-6. [Medline].

  6. Zerwekh JE. Bone disease and hypercalciuria in children. Pediatr Nephrol. Mar 2010;25(3):395-401. [Medline].

  7. Alon US, Berenbom A. Idiopathic hypercalciuria of childhood: 4- to 11-year outcome. Pediatr Nephrol. Sep 2000;14(10-11):1011-5. [Medline].

  8. Barratt TM, Duffy PG. Nephrocalcinosis and urolithiasis. Pediatr Nephrol. 1999;1:933-45.

  9. Biyikli NK, Alpay H, Guran T. Hypercalciuria and recurrent urinary tract infections: incidence and symptoms in children over 5 years of age. Pediatr Nephrol. 2005;20(10):1435-8. [Medline].

  10. Borghi L, Schianchi T, Meschi T, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. Jan 10 2002;346(2):77-84. [Medline].

  11. Burren CP, Curley A, Christie P, et al. A family with autosomal dominant hypocalcaemia with hypercalciuria (ADHH): mutational analysis, phenotypic variability and treatment challenges. J Pediatr Endocrinol Metab. 2005;18(7):689-99. [Medline].

  12. Gonzalez C, Ariceta G, Langman CB, Zibaoui P, Escalona L, Dominguez LF, et al. Hypercalciuria is the main renal abnormality finding in Human Immunodeficiency Virus-infected children in Venezuela. Eur J Pediatr. May 2008;167(5):509-15. [Medline].

  13. Heiliczer JD, Canonigo BB, Bishof NA, Moore ES. Noncalculi urinary tract disorders secondary to idiopathic hypercalciuria in children. Pediatr Clin North Am. Jun 1987;34(3):711-8. [Medline].

  14. Kang JH, Choi HJ, Cho HY, et al. Familial hypomagnesemia with hypercalciuria and nephrocalcinosis associated with CLDN16 mutations. Pediatr Nephrol. 2005;20(10):1490-3. [Medline].

  15. Polinsky MS, Kaiser BA, Baluarte HJ, Gruskin AB. Renal stones and hypercalciuria. Adv Pediatr. 1993;40:353-84. [Medline].

  16. Polito C, La Manna A, Cioce F. Clinical presentation and natural course of idiopathic hypercalciuria in children. Pediatr Nephrol. Dec 2000;15(3-4):211-4. [Medline].

  17. Richmond W, Colgan G, Simon S, et al. Random urine calcium/osmolality in the assessment of calciuria in children with decreased muscle mass. Clin Nephrol. 2005;64(4):264-70. [Medline].

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.